Article
Prostate cancer stem cell dynamics in the evolution of drug resistance
4 Jun 2025
Abstract excerpt
Prostate cancer remains a leading cause of cancer-related mortality in men worldwide, with tumor heterogeneity, therapy resistance, and lineage plasticity posing significant clinical challenges. Androgen deprivation therapy (ADT), while initially effective, often culminates in castration-resistant prostate cancer, may fueled by castration-resistant prostate cancer stem cells (CSCs) with adaptive self-renewal and...
Topics
Join the communities discussing this publication.
